Valiant Laboratories Limited (NSE:VALIANTLAB)
111.98
-1.22 (-1.08%)
Jul 1, 2025, 3:29 PM IST
Valiant Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 759.91 | 117.18 | 12.62 | 1.31 |
Short-Term Investments | - | 1,321 | 340.99 | - |
Cash & Short-Term Investments | 759.91 | 1,438 | 353.6 | 1.31 |
Cash Growth | -47.16% | 306.74% | 26830.85% | - |
Accounts Receivable | 721.22 | 457.27 | 885.68 | 1,108 |
Other Receivables | - | 18.74 | 7.22 | 0.08 |
Receivables | 721.84 | 476.32 | 893.61 | 1,108 |
Inventory | 39.89 | 100.15 | 130.42 | 158.04 |
Prepaid Expenses | - | 1.44 | 5.19 | 1.52 |
Other Current Assets | 404.54 | 239.3 | 122.96 | 228.56 |
Total Current Assets | 1,926 | 2,255 | 1,506 | 1,497 |
Property, Plant & Equipment | 2,041 | 927.03 | 487.98 | 236.72 |
Long-Term Investments | - | - | - | 4.02 |
Other Intangible Assets | 1.08 | - | - | - |
Other Long-Term Assets | 40.22 | 244.41 | 135.89 | 6.1 |
Total Assets | 4,009 | 3,427 | 2,130 | 1,744 |
Accounts Payable | 407.16 | 259.27 | 472.96 | 397.24 |
Accrued Expenses | 2 | 12.39 | 19.05 | - |
Short-Term Debt | - | 13.88 | - | - |
Current Portion of Long-Term Debt | 168.56 | - | - | 12.81 |
Current Portion of Leases | 2.31 | 2.31 | 1.75 | 1.78 |
Other Current Liabilities | 16.13 | 2.92 | 13.49 | 8.37 |
Total Current Liabilities | 596.16 | 290.77 | 507.26 | 420.21 |
Long-Term Debt | 1,043 | 746.63 | 594 | 594 |
Long-Term Leases | 2.51 | 4.27 | 6.42 | 2.67 |
Long-Term Deferred Tax Liabilities | 12.42 | 6.18 | 6.66 | 2.96 |
Other Long-Term Liabilities | 10.9 | 10.42 | 10.4 | 9.61 |
Total Liabilities | 1,665 | 1,058 | 1,125 | 1,029 |
Common Stock | 434.5 | 434.5 | 325.6 | 162.8 |
Additional Paid-In Capital | - | 1,413 | 163.39 | - |
Retained Earnings | - | 520.87 | 515.92 | - |
Comprehensive Income & Other | 1,909 | - | - | 551.8 |
Shareholders' Equity | 2,343 | 2,369 | 1,005 | 714.6 |
Total Liabilities & Equity | 4,009 | 3,427 | 2,130 | 1,744 |
Total Debt | 1,217 | 767.08 | 602.18 | 611.26 |
Net Cash (Debt) | -456.96 | 671.15 | -248.58 | -609.95 |
Net Cash Per Share | -10.59 | 17.66 | -7.63 | -18.73 |
Filing Date Shares Outstanding | 43.98 | 43.45 | 32.56 | 32.56 |
Total Common Shares Outstanding | 43.98 | 43.45 | 32.56 | 32.56 |
Working Capital | 1,330 | 1,965 | 998.52 | 1,077 |
Book Value Per Share | 53.28 | 54.51 | 30.86 | 21.95 |
Tangible Book Value | 2,342 | 2,369 | 1,005 | 714.6 |
Tangible Book Value Per Share | 53.26 | 54.51 | 30.86 | 21.95 |
Land | - | 226.48 | 226.48 | - |
Buildings | - | 121.99 | 120.09 | 95.24 |
Machinery | - | 338.37 | 301.26 | 147.47 |
Construction In Progress | - | 426.49 | 6.8 | 14.45 |
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.